NCT05944029

Effect of Pomegranate Seed Powder on Markers of Metabolic Syndrome

Name: Clinical Trial NCT05944029
Creator: Asif Ali
Keywords: Metabolic Syndrome, Pomegranate seed powder, dietary supplement, clinical trial, Pakistan

Therapeutic Effects of Pomegranate Seed Powder on Metabolic Syndrome Markers

Asif Ali·ClinicalTrials.gov·dietary supplementRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Metabolic Syndrome
Drug/Device/Intervention: Pomegranate seed powder
Study type: Interventional
Intervention type: dietary supplement

Sponsor & location

Primary sponsor: Asif Ali
Funder: University of Veterinary and Animal Sciences, Lahore - Pakistan
Location: Lahore, Pakistan

Timeline & enrollment

Phase: N/A
Start date: Feb 20, 2023
End date: Aug 24, 2023
Enrollment: 50 participants

Primary outcome

Lipid Profile,Fasting Glucose,Blood Pressure,Weight

Summary

Metabolic syndrome is a public health concern worldwide and in Pakistan as well. Abdominal obesity, hyperglycemia, hypertriglyceridemia, hypertension, and low HDL cholesterol are its hallmarks while pomegranate seed's unique chemical composition has sparked research into the health benefits in same arena as weight control, blood lipid profile changes, and other metabolic disturbances. It's high time to study therapeutic efficiency of Pomegranate seed powder against metabolic syndrome.

ICD-10 classifications

Metabolic disordersMetabolic disorder, unspecifiedOther metabolic disordersOther specified metabolic disordersNutritional and metabolic disorders in diseases classified elsewhere

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05944029
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05944029 through Pure Global AI's free database. This phase not specified trial is sponsored by Asif Ali and is currently Recruiting. The study focuses on Metabolic Syndrome. Target enrollment is 50 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.